This finding has important implications for the evaluation of diagnostically-challenging tumors of the ovary, where HNF1B has been proposed, as part of a diagnostic panel, to distinguish CCC from high-grade serous carcinomas [30]. Here, HNF1B is linked to serous adenocarcinoma.